Arizona Bioscience News: TGen’s $658M impact; European lab giant to Tucson; TRIF funding plans approved

December 2, 2021

By Matt Ellsworth

The University of Arizona Tech Park

Bioscience nonprofit spurs $658M economic impact on Arizona, report says / Phoenix Business Journal (AZ Inno)

TGen, a Phoenix-based nonprofit genomics research institute, created an economic impact of $657.7 million in 2020, tripling its impact from just three years before, a new Tripp Umbach report states.

A European lab giant is opening a Tucson site to support organ transplants / Arizona Daily Star

Eurofins CellTx, a major European laboratory services company, will open a new lab at the University of Arizona Science and Technology Park to provide services to the organ-transplant community by the second quarter of 2022. Read more: Eurofins CellTx will establish cellular therapy testing lab in Tucson

One year on, doctor says monoclonal antibodies underutilized / KJZZ

Monoclonal antibodies offer a safe, effective outpatient treatment for patients 12 and older who do not require oxygen or ventilation, but a lot of people are not aware of the treatment.

Here’s what Arizonans need to know about the coronavirus variant omicron / Arizona Republic

A newly detected variant of the virus that causes COVID-19 could complicate efforts to control the pandemic, but Arizona public health officials say more investigation is needed to clearly understand the situation. Read more: ASU virologist predicted a variant like omicron would come

Regents approve millions in new research funding for Arizona’s public universities / Phoenix Business Journal (AZ Inno)

The Arizona Board of Regents approved new technology-focused funding plans for Arizona State University, Northern Arizona University and the University of Arizona from the Technology and Research Initiative Fund, or TRIF, with ASU and UArizona receiving $32 million annually with NAU receiving $16 million per year over the next three years. Read more: University of Arizona sets $1 billion research expenditure goal

Skysong startups surpass $1 billion in external funding / AZ Big Media

Arizona State University has passed more than $1 billion raised in external funding by the startups in its portfolio at Skysong Innovations, the entity that brings ASU research into the marketplace.

University of Arizona researchers testing new ways to fight bacterial infections / Arizona Daily Star

A discovery by a University of Arizona research team could provide a new way to fight bacterial infections that cause pneumonia, meningitis, sepsis and even the fungus linked to Valley fever.

ACE Awards Innovator of the Year: Paradigm Labs grew rapidly to win contracts to provide COVID-19 testing / Phoenix Business Journal

During the coronavirus pandemic, Paradigm Labs of Tucson grew from 12 to 240 employees and now has three labs in Phoenix and Tucson, processing more than 1.5 million COVID-19 tests and achieving certification to administer the vaccines.

With the holidays looming, experts make recommendations for COVID-19 boosters / Arizona Republic

When it comes to booster shots against COVID-19, public health officials, researchers, doctors, and patients are trying to answer how we know if we need reinforcements and, if so, when is the best time to send them in.

Upcoming Events

December 9: AZBio Trailblazer Awards and Legislator Appreciation Luncheon

December 21: AZBioPEERS: Health IT Cyber Security

Sign up to receive Arizona Bioscience News weekly

Search the Arizona BioMap